PATHOLOGY OF RENAL-ARTERIES OF DYSLIPIDEMIC CHILDREN WITH CONGENITAL NEPHROSIS

被引:9
作者
ANTIKAINEN, M
SARIOLA, H
RAPOLA, J
TASKINEN, MR
HOLTHOFER, H
HOLMBERG, C
机构
[1] UNIV HELSINKI,DEPT PEDIAT 1,HELSINKI,FINLAND
[2] UNIV HELSINKI,DEPT PEDIAT 2,HELSINKI,FINLAND
[3] UNIV HELSINKI,DEPT INTERNAL MED 3,HELSINKI,FINLAND
[4] UNIV HELSINKI,DEPT BACTERIOL & IMMUNOL,HELSINKI,FINLAND
关键词
NEPHROTIC SYNDROME; ATHEROSCLEROSIS; ENDOTHELIAL INJURY; SMOOTH MUSCLE CELL PROLIFERATION;
D O I
10.1111/j.1699-0463.1994.tb04857.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Congenital nephrotic syndrome of the Finnish type (CNF) is well characterized in infants and associated with major lipid risk factors for atherosclerosis. This study was undertaken to investigate if any arterial pathology is present in children with CNF and, if so, to describe its nature in renal arteries collected at nephrectomy at a mean age of 12.5 +/- 4.4 months. Denuded endothelial injury and intimal thickening were seen in 9 out of 10 patient specimens of renal arteries. Intimal thickening contained loose abundant extracellular matrix with a few smooth muscle or myofibroblastoid cells. Only a few Sudan black- or oil red O-positive lipid droplets were found in six and seven samples, respectively. Areas immunoreactive with antibodies against apoprotein B were seen in only two specimens. Immunohistochemistry did not reveal any activated T or B cells, or any expression of IL-1 or IL-2 receptors. Macrophages were present in only two specimens. No foam cells were seen. We conclude that the vascular pathology together with altered lipoprotein metabolism indicates that children with CNF might be at risk for early atherosclerotic arterial disease, particularly if their hyperlipidemia persists.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 20 条
[1]  
ANTIKAINEN M, 1992, CLIN NEPHROL, V38, P254
[2]   CHANGES IN BIOLOGICAL-ACTIVITY AND IMMUNOREACTIVE MASS OF LIPOPROTEIN-LIPASE IN CONGENITAL NEPHROSIS - RELATIONSHIP TO HYPERTRIGLYCERIDEMIA [J].
ANTIKAINEN, M ;
HOLMBERG, C ;
OLIVECRONA, T ;
BENGTSSONOLIVECRONA, G ;
LABEUR, C ;
ROSSENEU, M ;
TASKINEN, MR .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (06) :368-374
[3]  
BADIMON L, 1992, J HYPERTENS, V10, pS43
[4]   SERUM LIPID AND LIPOPROTEIN ALTERATIONS IN NEPHROSIS [J].
BAXTER, JH ;
GOODMAN, HC ;
HAVEL, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 1960, 39 (03) :455-465
[5]   ENDOTHELIAL-CELL INFLUENCES ON VASCULAR SMOOTH-MUSCLE PHENOTYPE [J].
CAMPBELL, JH ;
CAMPBELL, GR .
ANNUAL REVIEW OF PHYSIOLOGY, 1986, 48 :295-306
[6]   HYPERLIPEMIA IN UNTREATED NEPHROTIC SYNDROME, INCREASED PRODUCTION OR DECREASED REMOVAL [J].
CHAN, MK ;
PERSAUD, JW ;
RAMDIAL, L ;
VARGHESE, Z ;
SWENY, P ;
MOORHEAD, JF .
CLINICA CHIMICA ACTA, 1981, 117 (03) :317-323
[7]  
CLOWES AW, 1986, LAB INVEST, V54, P295
[8]  
CONSTANTINIDES P, 1989, Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie, V135, P517
[9]   STATUS OF CORONARY-ARTERIES IN NEPHROTIC SYNDROME - ANALYSIS OF 20 NECROPSY PATIENTS AGED 15 TO 35 YEARS TO DETERMINE IF CORONARY ATHEROSCLEROSIS IS ACCELERATED [J].
CURRY, RC ;
ROBERTS, WC .
AMERICAN JOURNAL OF MEDICINE, 1977, 63 (02) :183-192
[10]  
HALLMAN NIILO, 1967, ACTA PAEDIAT SCAND SUPPL, V172., P75